Ayrton Drugs Manufacturing Limited reported earnings results for the year ended June 30, 2016. For the period, the company reported revenue of GHC 38,772,241 against GHC 34,892,733 a year ago. Operating profit was GHC 5,458,945 against operating loss of GHC 3,576,718 a year ago. Profit before tax was GHC 3,243,763 against loss before tax of GHC 4,775,465 a year ago. Profit for the year was GHC 2,598,241 against loss for the year of GHC 4,822,000 a year ago. Basic and diluted earnings per share were GHC 0.0121 against basic and diluted loss per share of GHC 0.0224 a year ago. Net cash flows from operating activities were GHC 3,642,562 against net cash flows use in operating activities of GHC 4,014,595 a year ago. Purchase of property, plant and equipment was GHC 961,661 against GHC 2,434,723 a year ago.